Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York

Honorio Silva; Peter Stonier; Pravin Chopra; Jacob Coots; Domenico Criscuolo; Soneil Guptha; Stuart Jones; Sandor Kerpel-Fronius; Gustavo Kesselring; Xavier Luria; David Morgan; Eddie Power; Sam Salek; Gustavo Silva; Tamas Suto; Kamlesh Thakker; Pol Vandenbroucke

doi:10.3389/fphar.2024.1417036

Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York

Honorio Silva^*, Peter Stonier, Pravin Chopra, Jacob Coots, Domenico Criscuolo, Soneil Guptha, Stuart Jones, Sandor Kerpel-Fronius, Gustavo Kesselring, Xavier Luria, David Morgan, Eddie Power, Sam Salek, Gustavo Silva, Tamas Suto, Kamlesh Thakker, Pol Vandenbroucke

^*Corresponding author for this work

Institute of Pharmaceutical Science

Research output: Contribution to journal › Short survey › peer-review

1 Citation (Scopus)

Abstract

Introduction: The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King’s College London and the Global Medicines Development Professionals (GMDP) Academy, which aimed to address this need through a blended e-learning program. Methods: The collaboration developed a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a combination of asynchronous and synchronous e-learning methods. The program targeted a diverse range of professionals serving in areas related to Medical Affairs. Results: Over seven annual cohorts, 682 participants from eighty-six countries were enrolled in the program. The program’s effectiveness was assessed using Kirkpatrick’s model, showing elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant gains in competence at the cognitive level and leveraged performance. Notably, 70% of responding alumni reported significant improvement in their functions, corroborated by 30% of their supervisors. The further long-term impact of the program on their respective organization has not been established. Discussion: The GMDP Academy’s program has significantly contributed to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Its success highlights the importance of continuous education in keeping pace with the industry’s evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.

Original language	English
Article number	1417036
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1417036
Publication status	Published - 2024

Keywords

certification
continuing professional development
e-learning
King’s
life-long learning
medicines development
pharmaceutical medicine

Access to Document

10.3389/fphar.2024.1417036

Cite this

Silva, H., Stonier, P., Chopra, P., Coots, J., Criscuolo, D., Guptha, S., Jones, S., Kerpel-Fronius, S., Kesselring, G., Luria, X., Morgan, D., Power, E., Salek, S., Silva, G., Suto, T., Thakker, K., & Vandenbroucke, P. (2024). Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York. Frontiers in Pharmacology, 15, Article 1417036. https://doi.org/10.3389/fphar.2024.1417036

@article{c07a707ca3c84796b9649524caca5319,

title = "Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King{\textquoteright}s College, London and the GMDP Academy, New York",

abstract = "Introduction: The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King{\textquoteright}s College London and the Global Medicines Development Professionals (GMDP) Academy, which aimed to address this need through a blended e-learning program. Methods: The collaboration developed a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a combination of asynchronous and synchronous e-learning methods. The program targeted a diverse range of professionals serving in areas related to Medical Affairs. Results: Over seven annual cohorts, 682 participants from eighty-six countries were enrolled in the program. The program{\textquoteright}s effectiveness was assessed using Kirkpatrick{\textquoteright}s model, showing elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant gains in competence at the cognitive level and leveraged performance. Notably, 70% of responding alumni reported significant improvement in their functions, corroborated by 30% of their supervisors. The further long-term impact of the program on their respective organization has not been established. Discussion: The GMDP Academy{\textquoteright}s program has significantly contributed to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Its success highlights the importance of continuous education in keeping pace with the industry{\textquoteright}s evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.",

keywords = "certification, continuing professional development, e-learning, King{\textquoteright}s, life-long learning, medicines development, pharmaceutical medicine",

author = "Honorio Silva and Peter Stonier and Pravin Chopra and Jacob Coots and Domenico Criscuolo and Soneil Guptha and Stuart Jones and Sandor Kerpel-Fronius and Gustavo Kesselring and Xavier Luria and David Morgan and Eddie Power and Sam Salek and Gustavo Silva and Tamas Suto and Kamlesh Thakker and Pol Vandenbroucke",

note = "Publisher Copyright: Copyright {\textcopyright} 2024 Silva, Stonier, Chopra, Coots, Criscuolo, Guptha, Jones, Kerpel-Fronius, Kesselring, Luria, Morgan, Power, Salek, Silva, Suto, Thakker and Vandenbroucke.",

year = "2024",

doi = "10.3389/fphar.2024.1417036",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media S.A.",

}

Silva, H, Stonier, P, Chopra, P, Coots, J, Criscuolo, D, Guptha, S, Jones, S, Kerpel-Fronius, S, Kesselring, G, Luria, X, Morgan, D, Power, E, Salek, S, Silva, G, Suto, T, Thakker, K & Vandenbroucke, P 2024, 'Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York', Frontiers in Pharmacology, vol. 15, 1417036. https://doi.org/10.3389/fphar.2024.1417036

TY - JOUR

T1 - Blended e-learning and certification for medicines development professionals

T2 - results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York

AU - Silva, Honorio

AU - Stonier, Peter

AU - Chopra, Pravin

AU - Coots, Jacob

AU - Criscuolo, Domenico

AU - Guptha, Soneil

AU - Jones, Stuart

AU - Kerpel-Fronius, Sandor

AU - Kesselring, Gustavo

AU - Luria, Xavier

AU - Morgan, David

AU - Power, Eddie

AU - Salek, Sam

AU - Silva, Gustavo

AU - Suto, Tamas

AU - Thakker, Kamlesh

AU - Vandenbroucke, Pol

PY - 2024

Y1 - 2024

N2 - Introduction: The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King’s College London and the Global Medicines Development Professionals (GMDP) Academy, which aimed to address this need through a blended e-learning program. Methods: The collaboration developed a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a combination of asynchronous and synchronous e-learning methods. The program targeted a diverse range of professionals serving in areas related to Medical Affairs. Results: Over seven annual cohorts, 682 participants from eighty-six countries were enrolled in the program. The program’s effectiveness was assessed using Kirkpatrick’s model, showing elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant gains in competence at the cognitive level and leveraged performance. Notably, 70% of responding alumni reported significant improvement in their functions, corroborated by 30% of their supervisors. The further long-term impact of the program on their respective organization has not been established. Discussion: The GMDP Academy’s program has significantly contributed to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Its success highlights the importance of continuous education in keeping pace with the industry’s evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.

AB - Introduction: The field of Medicines Development faces a continuous need for educational evolution to match the interdisciplinary and global nature of the pharmaceutical industry. This paper discusses the outcomes of a 7-year collaboration between King’s College London and the Global Medicines Development Professionals (GMDP) Academy, which aimed to address this need through a blended e-learning program. Methods: The collaboration developed a comprehensive curriculum based on the PharmaTrain syllabus, delivered through a combination of asynchronous and synchronous e-learning methods. The program targeted a diverse range of professionals serving in areas related to Medical Affairs. Results: Over seven annual cohorts, 682 participants from eighty-six countries were enrolled in the program. The program’s effectiveness was assessed using Kirkpatrick’s model, showing elevated levels of satisfaction (over 4.0 on a five-point scale), suggesting significant gains in competence at the cognitive level and leveraged performance. Notably, 70% of responding alumni reported significant improvement in their functions, corroborated by 30% of their supervisors. The further long-term impact of the program on their respective organization has not been established. Discussion: The GMDP Academy’s program has significantly contributed to life-long learning in Medicines Development, addressing educational gaps and fostering interdisciplinary collaboration. Its success highlights the importance of continuous education in keeping pace with the industry’s evolving demands and underscores the potential of blended learning in achieving educational objectives in pharmaceutical medicine.

KW - certification

KW - continuing professional development

KW - e-learning

KW - King’s

KW - life-long learning

KW - medicines development

KW - pharmaceutical medicine

UR - http://www.scopus.com/inward/record.url?scp=85197434439&partnerID=8YFLogxK

U2 - 10.3389/fphar.2024.1417036

DO - 10.3389/fphar.2024.1417036

M3 - Short survey

AN - SCOPUS:85197434439

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1417036

ER -

Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this